VEGFA and cancer: At present, VEGFR1 is emerging as a predictive biomarker for anti-VEGF therapy in cancer [16, 17] Given this evidence, it is reasonable to believe that VEGFR1 must have a prominent signaling role, even though its signal transduction mechanism and functions are still not fully determined.